Wednesday, May 20, 2020

Strides Pharma To Conduct Trials For Potential COVID-19 Drug

Bengaluru-based Strides Pharma Science has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country.

from NDTV Profit - Latest https://ift.tt/2LKwsVr

No comments:

Post a Comment